相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microglial priming in neurodegenerative disease
V. Hugh Perry et al.
NATURE REVIEWS NEUROLOGY (2014)
CD4 T cells in immunity and immunotherapy of Alzheimer's disease
Alon Monsonego et al.
IMMUNOLOGY (2013)
Safety and biomarker effects of Solanezumab in patients with Alzheimer's disease
Martin Farlow et al.
ALZHEIMERS & DEMENTIA (2012)
Prolongation of prion disease-associated symptomatic phase relates to CD3+ T cell recruitment into the CNS in murine scrapie-infected mice
Antoine Sacquin et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
The anatomical and cellular basis of immune surveillance in the central nervous system
Richard M. Ransohoff et al.
NATURE REVIEWS IMMUNOLOGY (2012)
MHC-Independent Genetic Factors Control the Magnitude of CD4+ T Cell Responses to Amyloid-β Peptide in Mice through Regulatory T Cell-Mediated Inhibition
Cecile Toly-Ndour et al.
JOURNAL OF IMMUNOLOGY (2011)
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O. Rinne et al.
LANCET NEUROLOGY (2010)
Microglia in neurodegenerative disease
V. Hugh Perry et al.
NATURE REVIEWS NEUROLOGY (2010)
HLA-DR Alleles in Amyloid beta-Peptide Autoimmunity: A Highly Immunogenic Role for the DRB1*1501 Allele
Victor Zota et al.
JOURNAL OF IMMUNOLOGY (2009)
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2009)
An antigen-specific pathway for CD8 T cells across the blood-brain barrier
Ian Galea et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Aβ42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Rebecca Radde et al.
EMBO REPORTS (2006)
Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice
Michele A. Kutzler et al.
VACCINE (2006)
Aβ-induced meningoencephalitis is IFN-γ-dependent and is associated with T cell-dependent clearance of Aβ in a mouse model of Alzheimer's disease
A Monsonego et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman et al.
NEUROLOGY (2005)
Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from β-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide
MG Agadjanyan et al.
JOURNAL OF IMMUNOLOGY (2005)
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy
DA Gross et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Differences in the immune response to long term Aβ vaccination in C57BL/6 and B6D2F1 mice
TJ Seabrook et al.
VACCINE (2004)
Identification of two immunogenic domains of the prion protein-PrP-which activate class II-restricted T cells and elicit antibody responses against the native molecule
S Gregoire et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
A mouse model of human adaptive immune functions:: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice
A Pajot et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease
I Ferrer et al.
BRAIN PATHOLOGY (2004)
Immune responses against Aβ1-42 in HLA class II transgenic mice:: implications for Aβ1-42 immune-mediated therapies
P Das et al.
NEUROBIOLOGY OF AGING (2003)
Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease
A Monsonego et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide:: a case report
JAR Nicoll et al.
NATURE MEDICINE (2003)
Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases
H Neumann et al.
TRENDS IN NEUROSCIENCES (2002)
Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases
T Togo et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Immune hyporesponsiveness to amyloid β-peptide in amyloid precursor protein transgenic mice:: Implications for the pathogenesis and treatment of Alzheimer's disease
A Monsonego et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
C Janus et al.
NATURE (2000)
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
D Morgan et al.
NATURE (2000)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
Regulation by neurotransmitter receptors of serotonergic or catecholaminergic neuronal cell differentiation
S Mouillet-Richard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
